Douglas C. Higgins, RPh, FIACP

home / authors / douglas-c-higgins-rph-fiacp

Articles

USP Chapter : Nonsterile Compounding Pharmacy Air Flow Considerations

USP Chapter : Nonsterile Compounding Pharmacy Air Flow Considerations

Douglas C. Higgins, RPh, FIACP
September 10th 2018

USP Chapter presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.

Read More

Site Logo

USP Chapter : Personal Protective Equipment

Douglas C. Higgins, RPh, FIACP
September 4th 2018

United States Pharmacopeial Convention (USP) Chapter has many prerequisites for personal protective equipment

Read More

Site Logo

USP Chapter : Nonsterile Compounding Pharmacy Air Flow Considerations

Douglas C. Higgins, RPh, FIACP
July 16th 2018

USP Chapter 800 presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.

Read More

Latest Updated Articles

10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Gabapentin Differs From Pregabalin in Several Key Ways
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Semaglutide injecting pen on a white background, macro. Needle macro - Image credit: artmim | stock.adobe.com
Published: October 17th 2024 | Updated: October 23rd 2024
Concerns Linger About GLP-1 Agonists Despite Their Popularity
Vial with pneumococcal disease vaccine and syringe for injection.
Published: October 21st 2024 | Updated: October 23rd 2024
Pneumococcal 21-Valent Conjugate Vaccine Generates Positive Response in Adults at Increased Risk of Disease
Myasthenia Gravis disease blood test in doctor hand
Published: October 21st 2024 | Updated: October 23rd 2024
Myasthenia Gravis Negatively Impacts Patients and Care Partners Through Clinical, Financial Burdens
FDA Approval, Stelara, Biosimilar | Image Credit: Calin - stock.adobe.com
Published: October 1st 2024 | Updated: October 23rd 2024
FDA Approves Ustekinumab-Aauz as Biosimilar for Stelara